[Operative treatment of renal cell carcinoma]
1Klinik und Poliklinik für Urologie, Universitätsklinikum Aachen, Pauwelsstrasse 30, Aachen, Germany. aheidenreich@ukaachen.de
Abstract:
Renal cell carcinoma represents the fifth most frequent malignant tumor in humans. At the time of diagnosis, 20% of the patients already manifest metastases. A further 20-30% of the patients develop systemic metastases in the postoperative course. Despite continued advances in pharmacological treatment options, cancer surgery tailored to the individual tumor findings constitutes the only curative treatment option.
Insights
Renal cell carcinoma (RCC) is a common cancer. While treatments improve, surgery remains the only cure for this kidney cancer, even with metastases.
Area of Science:
- Oncology
- Urologic Oncology
Context:
- Renal cell carcinoma (RCC) is the fifth most common human malignancy.
- Metastases are present at diagnosis in 20% of patients.
- An additional 20-30% develop systemic metastases postoperatively.
Purpose:
- To highlight the current treatment landscape for renal cell carcinoma.
- To emphasize the role of surgery in curative treatment strategies.
Summary:
- Despite advances in systemic therapies, surgical intervention remains the cornerstone of curative treatment for renal cell carcinoma.
- Individualized surgical approaches are critical for managing localized and metastatic disease.
Impact:
- This underscores the continued importance of surgical oncology in improving outcomes for patients with kidney cancer.
- Highlights the need for integrated treatment strategies combining medical and surgical interventions.
More Related Videos
Related Concept Videos
Kidney Transplant II: Surgical Procedure
Urinary Tract Calculi VI: Surgical Management
Urinary Tract Calculi III: Medical Management
Kidney Transplant III: Nursing Management
Chronic Kidney Disease III: Interprofessional Care
Urinary Tract Calculi V: Nursing Management


